Ning Li

8PUBLICATIONS
1CO-AUTHORS
Molecular targetsCancer diagnosisEpidemiological modellingNeurology and neuromuscular diseasesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 16, 2026
Unraveling regorafenib resistance: metabolic reprogramming, tumor plasticity, and novel approaches to overcome therapy failure.

|Mar 10, 2026
Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities.

Mingkang Yu, Di Yang, Xiuli Chen

|Nov 27, 2025
EVA1A Regulates Hepatic Lipid Homeostasis by Modulating CD36 Expression and Its Palmitoylation.

Di Yang, Lianhui Li, Kailai Zang

|May 14, 2024
EVA1A reverses lenvatinib resistance in hepatocellular carcinoma through regulating PI3K/AKT/p53 signaling axis.

Xiaokun Liu, Xiao Gao, Yuling Yang

|Apr 16, 2024
A crazy trio in Parkinson's disease: metabolism alteration, α-synuclein aggregation, and oxidative stress.

Sheng Li, Yanbing Liu, Sen Lu

|Oct 23, 2022
Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration.

Qian Xu, Zhaozhong Liao, Zunshuang Gong

Pageof 2

Frequent Collaborators

1 joint publications

Tao Zhao